DRP1 depletion protects NK cells from hypoxia-induced dysfunction
Bron
Redox report: communications in free radical research - ISSN 1351-0002-31:1 (2026) p. 1-20
Rationally designed drug combination screen in more physiologically relevant in vitro organoid models : can we improve personalized therapy for pancreatic cancer?
Bron
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2026,186 p.
Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays
Bron
Communications Biology - ISSN 2399-3642-7:1 (2024) p. 1-11
"Keep on ROCKIn" : repurposed ROCK inhibitors to boost corneal endothelial regeneration
Bron
Biomedicine and pharmacotherapy - ISSN 0753-3322-174 (2024) p. 1-12
Auranofin repurposing for lung and pancreatic cancer : low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition
Bron
Journal of Experimental and Clinical Cancer Research - ISSN 1756-9966-43:1 (2024) p. 1-15